Towa Pharmaceutical (Japan)

Towa Pharmaceutical (Japan)

Open Access statistics for Towa Pharmaceutical (Japan), Japan, covering academic research published from 2000 to 2023.

Open Access statistics for Towa Pharmaceutical (Japan), Japan, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

54%


Total
Publications

307


Total Open
Publications

165


Total
Citations

4.4K


Open Access
Percentage

54%


Total
Publications

307


Total Open
Publications

165


Total
Citations

4.4K

Website

download

Breakdown

35% 16% 3% 46%

Publisher Open

35%

Both

16%

Other Platform Open

3%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

32

Hybrid 20%

31

No Guarantees 60%

93

Other Platform Open

Domain 74%

43

Public 17%

10

Institution 16%

9

Preprint 14%

8

Other Internet 3%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
42
Europe PMC
Domain
19
Semantic Scholar
Public
10
Research Square
Preprint
7
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit
Institution
2
Nagasaki University - Nagasaki University's Academic Output SITE
Institution
2
Indiana University - Purdue University Indianapolis - IUPUI ScholarWorks
Institution
2
University of Castilla La Mancha - Virtual Community of Pathological Anatomy
Institution
1
SRCE - University of Zagreb University Computing Centre - HRČAK - Portal of Croatian Scientific and Professional Journals
Institution
1
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Institution
1
1 / 2

Data updated 17 June 2024

Share

Share

Share